SureTrader SureTrader
Home > Boards > US Listed > Biotechs > Peregrine Pharmaceuticals (PPHM)

PPHM - O/S Shares History (’06–curr.) – a/o

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
cjgaddy Member Profile
 
Followed By 62
Posts 4,816
Boards Moderated 1
Alias Born 01/24/04
160x600 placeholder
New Study Demonstrates Anti-Tumor Advantages for Combination Treatment Featuring Peregrine Pharmaceuticals’ PS-Targeting An... "GlobeNewswire Inc." - 11/14/2016 8:05:00 AM
Preclinical Research Demonstrates Peregrine Pharmaceuticals’ PS-Targeting Antibodies Enhance the Anti-Tumor Activity of PD-... "GlobeNewswire Inc." - 10/24/2016 8:05:00 AM
Form 8-K - Current report "Edgar (US Regulatory)" - 10/13/2016 4:45:00 PM
Form 8-K - Current report "Edgar (US Regulatory)" - 10/12/2016 2:25:00 PM
Peregrine Pharmaceuticals Reports Top-Line and Initial Biomarker Data from Phase III SUNRISE Trial of Bavituximab in Oral Pre... "GlobeNewswire Inc." - 10/10/2016 8:05:00 AM
Could these companies be setting up for a rebound? "InvestorsHub NewsWire" - 10/6/2016 8:00:00 AM
Peregrine Pharmaceuticals Presents Preclinical Data Demonstrating PS-Targeting Antibodies Significantly Enhance the Anti-Tumo... "GlobeNewswire Inc." - 9/27/2016 8:05:00 AM
Peregrine Pharmaceuticals Provides Update on Oral Presentation of Top-Line Data from Phase III SUNRISE Trial of Bavituximab a... "GlobeNewswire Inc." - 9/21/2016 8:05:00 AM
Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2017 and Recent Developments "GlobeNewswire Inc." - 9/8/2016 4:05:00 PM
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock "GlobeNewswire Inc." - 9/6/2016 4:05:00 PM
National Comprehensive Cancer Network (NCCN) Awards Three Grants for Combination Studies of Peregrine Pharmaceuticals’ Bavi... "GlobeNewswire Inc." - 9/6/2016 8:45:00 AM
Peregrine to Report Financial Results for First Quarter of Fiscal Year 2017 After Market Close on September 8, 2016 "GlobeNewswire Inc." - 9/1/2016 4:05:00 PM
Avid Bioservices to Participate in Cambridge Healthtech Institute’s (CHI) 8th Annual The Bioprocessing Summit "GlobeNewswire Inc." - 8/9/2016 8:05:00 AM
Peregrine Pharmaceuticals Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2016 and Recent Developments "GlobeNewswire Inc." - 7/14/2016 4:05:00 PM
Peregrine Licenses Novel Exosome-Based Cancer Detection and Monitoring Technology from UT Southwestern Medical Center "GlobeNewswire Inc." - 7/14/2016 8:05:00 AM
Peregrine to Report Financial Results for the Quarter and Fiscal Year Ended April 30, 2016 After Market Close on July 14, 201... "GlobeNewswire Inc." - 7/7/2016 4:05:00 PM
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock "GlobeNewswire Inc." - 6/2/2016 4:00:00 PM
Peregrine Pharmaceuticals Provides Corporate Update Highlighting Latest Developments for Contract Manufacturing and Drug Deve... "GlobeNewswire Inc." - 6/2/2016 8:05:00 AM
Preclinical Data Presented at American Association for Cancer Research (AACR) Annual Meeting Demonstrate Enhanced Therapeutic... "GlobeNewswire Inc." - 4/20/2016 8:05:00 AM
Form 8-K - Current report "Edgar (US Regulatory)" - 4/12/2016 4:31:41 PM
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock "GlobeNewswire Inc." - 3/9/2016 7:46:45 PM
Peregrine Pharmaceuticals Announces Formal Commissioning of New, State-of-the-Art Commercial Manufacturing Facility "GlobeNewswire Inc." - 3/9/2016 7:46:43 PM
Peregrine to Report Financial Results for Third Quarter of Fiscal Year 2016 Prior to Market Open on March 9, 2016 "GlobeNewswire Inc." - 3/9/2016 7:46:38 PM
Peregrine Pharmaceuticals Provides Update on Phase III SUNRISE Trial of Bavituximab "GlobeNewswire Inc." - 3/9/2016 7:46:14 PM
Peregrine Pharmaceuticals Reports Financial Results for Third Quarter of Fiscal Year 2016 and Recent Developments "GlobeNewswire Inc." - 3/9/2016 8:00:00 AM
cjgaddy   Sunday, 08/19/12 09:42:23 AM
Re: cjgaddy post# 84300
Post # of 280165 
PPHM - O/S Shares History (’06–curr.) – a/o 8-16-12, shares outstanding = 104,191,176, up 17,120 since 7-13-12.

4-30-06 35,876,438
1-31-07 39,222,440
4-30-07 39,222,440
7-6-07 45,233,123
7-31-07 45,242,123
10-31-07 45,242,123
1-31-08 45,242,123
4-30-08 45,242,123
7-31-08 45,242,123
10-31-08 45,242,123
1-31-09 45,242,123
4-30-09 45,537,711
7-10-09 47,392,883
7-31-09 47,393,783
10-31-09 48,869,563 +1,475,780
1-31-10 50,903,404 +2,033,841
4-30-10 53,094,894 +2,191,490
6-21-10 54,388,917 +1,294,023 (6-22-10 ATM/mlv Form424)
7-9-10 55,069,449 +475,987 (4-30-10 10K iss. 7-14-10)
7-31-10 55,784,955 +715,506
10-31-10 59,220,742 +3,435,787
11-30-10 63,932,353 +4,711,611 (10-31-10 10Q iss. 12-9-10)
12-15-10 64,404,097 +471,744 (12-17-10 S-3: $75M Shelf Reg.)
1-31-11 66,813,419 +2,409,322
2-28-11 67,885,811 +1,072,392 (1-31-11 10Q iss. 3-11-11)
4-30-11 69,837,142 +1,951,331
7-8-11 71,069,858 +1,232,716 (4-30-11 10K iss. 7-14-11)
8-22-11 72,704,647 +1,634,789 (Proxy iss. 8-26-11)
8-31-11 73,284,016 +579,369 (424B5 iss. 9-2-11)
9-8-11 79,536,268 +6,252,252 (Roth Sale to 3 Inst’s @ $1.11/sh.)
10-31-11 82,638,201 +3,101,933
12-9-11 86,788,817 +4,150,616 (10-31-11 10Q iss. 12-12-11)
1-31-12 93,146,226 +6,357,409
2-29-12 98,873,172 +5,726,946 (1-31-12 10Q iss. 3-9-12)
4-30-12 101,421,365 +2,548,193
7-13-12 104,174,056 +2,752,691 (4-30-12 10K iss. 7-16-12)
8-16-12 104,191,176 +17,120** (prelim. proxy 14A http://tinyurl.com/c48bvof )

**8-15-12: CEO STEVE KING'S 29MIN. TALK AT WEDBUSH/NYC http://tinyurl.com/8mhrtld
…SK: "We've laid out our strategy for financing the company; we've not been raising money thru the capital markets in any way. We're not currently planning on going out for, nor have we been actively involved in any other fund-raising activities. Right now, our stated goal is to pursue a debt-arrangement - with an asset like Avid Bioservices, we can get very preferential rates on raising debt-type funding right now, which we feel is the least-dilutive for the company. In fact, our stated goal is to raise $20-30mm thru a debt facility between now and out next earnings call on Sept. 10, 2012. With that capital in the bank, we’ll then will have a 1yr+ runway. We believe that will get us thru the partnering discussions, and then with a partner on board, then certainly we expect that’ll bring in the capital needed to move the company forward for what should hopefully be several years time period. So, that’s our goal – we have a nice, clean cap structure, minimal # of warrants, stock options – there’s no convertible debt on the books, so we think we’re in good shape as we continue to move the company forward into those successful partnering discussions.”

O/S WARRANTS & STOCK-OPTIONS A/O 4-30-2012:
From the 4-30-12 10-K (pg. F-30 & F-28):
...219,967 warrants o/s with wgt.avg. exercise price of $1.48 (exp. 12-19-2013) – none iss. in FY10-11-12.
...7,402,248 stock options exercisable & expected to vest, with a wgt.avg. exercise price of $2.93.

= = = = = = = = = = = = =
Latest 10K 4-30-12 iss. 7-16-12: http://tinyurl.com/79o57b2 PR: http://tinyurl.com/c8nytow (#Cash 4-30-12 $18.0mm)
= > # CFO Paul Lytle, 7-16-12 CC: ”Since 5-1-12, the start of FY’13, we have received over $7 million in customer deposits to secure this future mfg. capacity. Based on the current mfg. schedule, we expect to realize the revenue from these mfg. commitments over FY '13 and FY '14.” ( http://tinyurl.com/cs7spbz )
Latest 10Q 1-31-12 iss. 3-9-12 http://tinyurl.com/7h352ks PR: http://tinyurl.com/7z9qh23 (Cash 1-31-12 $19.8mm)
ALL SEC filings for PPHM: http://tinyurl.com/6d4jw8
PPHM's Corp. Bylaws (a/o 12-21-07): http://www.secinfo.com/dV3p8.u4av.d.htm
Poison Pill adopted 3-16-06: http://tinyurl.com/yvypvh - 44-pg SEC filing: http://tinyurl.com/5m57ut

= = = = = = = = = = = = = = = = = = =
A-T-M (At-The-Market) Sales 3-2009 - 6-30-12 ($89,674,000gr./51,785,558sh=$1.73/sh): http://tinyurl.com/bnd6o7d
…New ATM Agreement (up to $75mm) with MLV announced 12-29-10/8K: http://tinyurl.com/2a6w76g
...3-9-12: PPHM files shelf to sell up to $150mm common stock, warrants, S3: http://tinyurl.com/7dl7pjm

11-8-10: Kenneth Dart (Eastern Capital) acquires 7.1% stake (3,961,568) in PPHM http://tinyurl.com/24qctos
...2-14-12: Kenneth Dart adds 3,460,192, now 7,421,760 (8.55% a/o 12-9-11) http://tinyurl.com/7bb26j4

12-31-10: BlackRock Inc. (Larry Fink, CEO) accums 5.6% stake in Peregrine http://tinyurl.com/4oercf8

7-23-12: Ayer Capital Mgt. accums 5.39% stake in PPHM (5,610,236) http://tinyurl.com/97w8gjm

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist